Contemporary Concise Review 2020: Interstitial lung disease.

Area of Science:

• Pulmonology
• Respiratory Medicine
• Critical Care

Background:

• The year 2020 presented unprecedented challenges due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
• Despite global disruptions, research in interstitial lung disease (ILD) continued to progress significantly.

Purpose of the Study:

• To review and summarize key interstitial lung disease (ILD) research published in 2020.
• To highlight the impact of these studies on the diagnosis and management of ILD.

Main Methods:

• Literature review of significant studies published in 2020 concerning interstitial lung disease (ILD).
• Analysis of research advancements in diagnostic tools, biomarkers, therapeutic agents, and supportive care strategies for ILD.
• Inclusion of studies examining the impact of coronavirus disease 2019 (COVID-19) on ILD management.

Main Results:

• Significant progress was made in developing new diagnostic tools and identifying potential biomarkers for ILD.
• Studies explored the efficacy of antifibrotic therapies and novel therapeutic agents for ILD.
• Research also focused on supportive care strategies and the influence of COVID-19 on ILD patient management.

Conclusions:

• The landscape of ILD management is being reshaped by recent research findings.
• Continued investigation into diagnostics, therapies, and the impact of emerging diseases like COVID-19 is crucial for advancing ILD care.